News

On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...
There are two vaccines approved by the FDA -- RotaTeq and Rotarix -- that protect against rotavirus, the most common cause of ...
A nanoparticle-based vaccine candidate for H5N1 avian influenza achieved 100% protection in preclinical trials, offering hope ...
According to the US' CDC, the ongoing clade II 2022 mpox outbreak has been responsible for over 100,000 infections in 122 countries to date worldwide.
Under direction of Health Secretary Robert F. Kennedy Jr., the CDC is considering changes to its recommendations on vaccines ...
US Advisory Committee on Immunization Practices recommends approval of GSK’s RSV vaccines, Arexvy for adults aged 50-59: London, UK Saturday, April 19, 2025, 09:00 Hrs [IST] GSK ...
The U.S. is experiencing an outbreak of measles and is on track to have the most whooping cough cases since 1948; these ...
A UB study found that the vaccine platform, proven effective for COVID-19, could be key in responding to evolving bird flu ...
BUFFALO, NY, USA I April 17, 2025 I As H5N1 avian influenza continues its spread across species and continents, a vaccine being developed by University of ...
The recent success of an experimental bird flu vaccine in trials marks a significant step forward in the fight against avian influenza. Researchers from the University of Buffalo have demonstrated ...
The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...